{"id":"NCT00558064","sponsor":"Boehringer Ingelheim","briefTitle":"Filtered Trial for Amlodipine Non-responder","officialTitle":"Filtered Trial for Amlodipine Non-responder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-10","primaryCompletion":"2008-09","completion":null,"firstPosted":"2007-11-14","resultsPosted":"2010-02-01","lastUpdate":"2014-07-08"},"enrollment":531,"design":{"allocation":null,"model":"PARALLEL","masking":null,"primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"telmisartan+amlodipine","otherNames":[]},{"type":"DRUG","name":"amlodipine","otherNames":[]}],"arms":[],"summary":"To demonstrate that a fixed-dose combination of telmisartan 40 mg plus amlodipine 5 mg is superior to amlodipine 5 mg alone in patients with essential hypertension and inadequately controlled with amlodipine 5 mg monotherapy.","primaryOutcome":{"measure":"Reduction From Reference Baseline in Mean Seated Diastolic Blood Pressure at Trough (24-hour Post-dosing)","timeFrame":"Baseline and 8 Weeks","effectByArm":[{"arm":"Telmisartan 40 mg Plus Amlodipine 5 mg Fixed-dose Combination","deltaMin":9.56,"sd":0.61},{"arm":"Amlodipine 5 mg Monotherapy","deltaMin":4.45,"sd":0.61}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":41,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":269},"commonTop":["Nasopharyngitis"]}}